Cited by 389Dermatology and Skin DiseasesContact Dermatitis and AllergiesAsthma and respiratory diseases

The DOI matches its Crossref record; 60 of the 63 references it cites were found in a registry or an index.

What are the best outcome measurements for atopic eczema? A systematic review

Schmitt, Jochen, Langan, Sinead, Williams, Hywel C.·2007·Journal of Allergy and Clinical Immunology

DOI 10.1016/j.jaci.2007.08.011

Open this paper in CoChat — free account

Abstract

Background Valid and reliable outcome measurements are a prerequisite for evidence-based practice. The comparative validity and reliability of outcome measurements for assessing atopic eczema (AE) severity is unclear.Objective We sought to assess the validity, reliability, sensitivity to change, and ease of use of outcome measurements for AE. We also sought to give recommendations on which outcomes to use in clinical research and for clinical monitoring.Methods We performed a systematic review and survey of clinical experts and patients.Results Twenty published outcome measurements were identified. There is evidence of adequate construct validity for 3 measurements (Severity Scoring of Atopic Dermatitis index [SCORAD], Eczema Area and Severity Index [EASI], and Three Item Severity Score), adequate internal consistency of 1 scale (Patient-oriented Eczema Measure [POEM]), adequate interobserver reliability of 5 measurements (Basic Clinical Scoring System; Nottingham Eczema Severity Score; Objective Severity Assessment of Atopic Dermatitis; Six Area, Six Sign Atopic Dermatitis severity score; and SCORAD), adequate test-retest reliability of 1 scale (POEM), and adequate sensitivity to change of 3 measurements (EASI, SCORAD, and Investigators' Global Atopic Dermatitis Assessment). Most outcome measurements have adequate content validity, as assessed by patients and experts. Data on the time to perform the assessment was identified for 8 outcome measurements. Only SCORAD, EASI, and POEM have been tested sufficiently and performed adequately.Conclusion There are too many published outcome measures for AE. Most have not been tested properly or perform adequately when tested, and their continued use hampers scientific communication.Clinical implications Only SCORAD, EASI, and POEM currently perform adequately. These scales should be used in future studies.

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2007.08.011

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Principles and Practice of Structural Equation Modeling
Tabri, N., & Elliott, C. M. (2012) · Canadian Graduate Journal of Sociology and Criminology · doi:10.15353/cgjsc.v1i1.3787 · Cited by 39,094
Untitled work
(1998) · Cited by 36,049
Health Measurement Scales: A Practical Guide to Their Development and Use
Streiner, D. L., Norman, G. R., & Cairney, J. (1989) · Cited by 9,595
Untitled work
(2005) · Cited by 6,097
Atopic Dermatitis
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,597
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
Health Measurement Scales: A Practical Guide to Their Development and Use
Vogelzang, J. L. (2015) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2015.03.007 · Cited by 2,393
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,304
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.100102.x · Cited by 1,200
Atopic dermatitis
Leung, D. Y. M., & Bieber, T. R. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12193-9 · Cited by 1,164

Flagged first, then by citations

Show all 63 references

3 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Mastrandrea, 2005, Allerg Immunol (Paris), 37, 357

Sorted by citations

Items 301–389 of 389

Dermatite atopique de l’enfant : quand penser à l’allergie alimentaire ?
Mailhol, C., Giordano‐Labadie, F., Ammoury, A., Lauwers‐Cancès, V., Paul, C. F., & Rancé, F. (2010) · Revue française d'allergologie · doi:10.1016/s1877-0320(10)70008-7 · Cited by 3
Dermatoepidemiologie
Apfelbacher, C., Diepgen, T. L., & Weißhaar, E. (2011) · Der Hautarzt · doi:10.1007/s00105-011-2175-0 · Cited by 3
“In klinischen Studien werden häufig unterschiedliche Zielgrößen mit fraglicher Validität eingesetzt, selbst wenn es sich um die Untersuchung der gleichen Dermatose handelt [22].”
Background
Impact of the COVID-19 pandemic and lockdown on the clinical response to dupilumab treatment and the psychological status of non-infected atopic patients
Rovati, C., Rossi, M., Gelmetti, A., Tomasi, C., Calzavara‐Pinton, I., Venturini, M., Calzavara‐Pinton, P., & Arisi, M. (2021) · European Journal of Dermatology · doi:10.1684/ejd.2021.4135 · Cited by 3
Assessment of the severity of atopic dermatitis — SCORAD and EASI
Karamova, A. Е., Chikin, V. V., Znamenskaya, L. F., & Aulova, K. M. (2022) · Vestnik dermatologii i venerologii · doi:10.25208/vdv1335 · Cited by 3
General Aspects of Treatment
Finlay, A. Y., & Smith, C. H. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch72 · Cited by 3
How to Critically Appraise a Randomized Controlled Trial
Williams, H. C. (2014) · Wiley eBooks · doi:10.1002/9781118357606.ch9 · Cited by 3
Efficacy and safety of specific immunotherapy with aeroallergens in the management of atopic dermatitis
Anggraeni, S., Damayanti, D., Umborowati, M. A., Riswanto, C. D., Rhatomy, S., Notobroto, H. B., Endaryanto, A., Effendy, I., & Prakoeswa, C. R. S. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns9.12958 · Cited by 2
Is there room for allergen immunotherapy for the treatment of atopic dermatitis in the precision medicine era?
Pessina, B., Giovannini, M., Mori, F., Cara, G. D., Novembre, E. M., Chan, S., Flohr, C., & Toit, G. D. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1050560 · Cited by 2
“, the Patient-Orientated Eczema Measure – POEM) (17).”
Role of Mannose-binding Lectin and Association with Microbial Sensitization in a Cohort of Patients with Atopic Dermatitis
Belfrage, E., Jinnestål, C. L., Jönsen, A., Bengtsson, A. A., Åkesson, A., Schmidtchen, A., & Sonesson, A. (2023) · Acta Dermato Venereologica · doi:10.2340/actadv.v103.2405 · Cited by 2
“Disease severity of AD was determined (28, 29) (see Appendix S1).”
A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls
Barnes, C. J., Asplund, M., Clausen, M., Rasmussen, L., Olesen, C. M., Yüksel, Y. T., Andersen, P. S., Litman, T., Holmstrøm, K., Bay, L., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03012-7 · Cited by 2
“7) [32], while all participants underwent a screening for filaggrin mutations within the R501X, 2282del4 and R2447X genes [14].”
Background
Exploring genetic associations between metabolites and atopic dermatitis: insights from bidirectional Mendelian randomization analysis in European population
He, A., Hong, Z., Zhao, X., Li, H., Xu, Y., Xu, Y., Jing, Z., Ma, H., Gong, Z., Yang, B., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1451112 · Cited by 2
The Patient‐Oriented Eczema Measure: estimating the minimal important change in an outpatient clinic cohort
Yew, Y. W., Zhao, X., & Apfelbacher, C. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16122 · Cited by 2
[Short version of a quality-of-life questionnaire in primary caregivers of children with atopic dermatitis (QPCAD): development and validation of QP9].
Katsunuma, T., Tan, A., & Ohya, Y. (2013) · PubMed · doi:10.15036/arerugi.62.33 · Cited by 8
Clinical Scoring of Atopic Dermatitis
Honari, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-32383-1_94 · Cited by 2
Treating eczema in children in general practice
Onselen, J. V. (2018) · Practice Nursing · doi:10.12968/pnur.2018.29.5.223 · Cited by 2
Atopic dermatitis in children. A current algorithm for the disease treatment and control
Proshutinskaya, D. V. (2016) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2016-92-2-65-70 · Cited by 2
The effect of balneotherapy with natural mineral dissolved water on dry skin in atopic dermatitis: A phase IIa, nonrandomized, controlled study
Uchiyama, A., Fujiwara, C., Inoue, Y., Uchida, K., Hiyama, M., Itabashi, H., & Motegi, S. (2021) · Journal of Cutaneous Immunology and Allergy · doi:10.1002/cia2.12195 · Cited by 2
Assessment of atopic eczema severity with EASI
Rob, F., & Hercogova, J. T. (2020) · Dermatologie pro praxi · doi:10.36290/der.2020.001 · Cited by 2
Atopic Dermatitis: Scoring Severity and Quality of Life Assessment
Lewis‐Jones, M. S., & Charman, C. R. (2011) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781444345384.ch29 · Cited by 2
Chinese herbal medicine for atopic eczema
Gu, S., Pang, C., Xue, C. C., Li, C. G., Yang, A. W., Zhang, W., & Williams, H. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008642 · Cited by 2
Principles of Measurement and Assessment in Dermatology
Finlay, A. Y. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0016 · Cited by 2
Reply to “Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A two‐year case series of patient‐reported outcomes”
Rajkumar, J. R., Jetter, N., Samuels, K., & Schwartz, A. (2021) · Pediatric Dermatology · doi:10.1111/pde.14611 · Cited by 2
Disease burden, clinical management and unmet treatment need of patients with moderate to severe atopic dermatitis; consensus statements, insights and practices from CERTADE (Central/Eastern EU, Russia, Turkiye AD Experts) Delphi panel
Trzeciak, M., Rudnicka, L., Arenberger, P., Engіn, B., Lvov, A. N., Alper, S., Alpsoy, E., Benáková, N., Bobko, S., Borlu, M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1402493 · Cited by 1
Validation of IGA*BSA in Assessing Disease Severity and Response in Patients with Atopic Dermatitis: A Retrospective Cohort Study in China
Yang, C., Wu, X., He, J., Liao, Y., Chen, J., & Dou, X. (2024) · Dermatitis · doi:10.1089/derm.2024.0226 · Cited by 1
Atopic Dermatitis Activity Score 7 (ADAS7): A tool for disease activity assessment
Greef, A. D., Degraeuwe, A., Nielens, N., Darrigade, A. ‐., Bugli, C., de Montjoye, L., & Baeck, M. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12393 · Cited by 1
Effects of Probiotic Supplementation in Adults with Atopic Dermatitis: A Meta-Analysis
Agamy, A. M., & Chen, H.-H. (2025) · Journal of Dermatology Research · doi:10.46889/jdr.2025.6216 · Cited by 1
“Safety was with very few side effects (e.g., short gastrointestinal upset, in contrast to corticosteroid-associated dangers such as skin atrophy [7,13,22,26-28].”
Influential
¿Qué pruebas complementarias son útiles en el diagnóstico y manejo de la dermatitis atópica?
Serra‐Baldrich, E. (2015) · Piel · doi:10.1016/j.piel.2015.06.001 · Cited by 1
Messung der Erkrankungsschwere in der Dermatologie
Deckert, S., Apfelbacher, C., & Schmitt, J. M. (2015) · Der Hautarzt · doi:10.1007/s00105-015-3663-4 · Cited by 1
Reliability and Validity of Patient Oriented Eczema Measure (POEM) Korean Version
Kim, Y.-H., Han, J., Jung, I. C., Kang, W., & Park, Y. (2016) · 대한한의학회지 · doi:10.13048/jkm.16044
The Efficacy Of Using Tacrolimus Ointment On Children With Atopic Dermatitis
Mohammad, S., & Siddiqui, M. (2012) · Cited by 1
Fluorescent fibre‐optic confocal characterization of in vivo epidermal changes in atopic eczema
Suihko, C., & Serup, J. V. (2020) · Skin Research and Technology · doi:10.1111/srt.12825 · Cited by 1
Real-life efficiency and safety comparison study of emollient ointment based on glycerophosphoinositol (GPI) salt of choline and other emollient products in patients with atopic dermatitis
Marko, M., & Pawliczak, R. (2020) · Journal of Dermatological Treatment · doi:10.1080/09546634.2020.1800567 · Cited by 1
Assessment of oxygen saturation in microvasculature of atopic dermatitis patients using multispectral optoacoustic mesoscopy
Moothanchery, M., Attia, A. B. E., Li, X., Weng, Y. Y., Thng, S. T. G., Dinish, U. S., & Olivo, M. (2022) · Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases · doi:10.1117/12.2610600 · Cited by 1
“For example, Eczema Area Severity Index (EASI) or Scoring AD (SCORAD) rely on direct inspection of the skin but is limited by intra- and inter-observer variations depending on the assessors’ experience [3, 4].”
Background
Severity strata for five patient-reported outcomes in adults with atopic dermatitis
Vakharia, P. P., Chopra, R., Sacotte, R. M., Patel, N., Immaneni, S., White, T., Kantor, R. W., Hsu, D. Y., Simpson, E. L., & Silverberg, J. I. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16512 · Cited by 1
Epidemiology
Flohr, C., & Williams, H. C. (2009) · CRC Press eBooks · doi:10.3109/9781420077995-3 · Cited by 1
Eczema.
Schmitt, J. M., Apfelbacher, C., & Flohr, C. (2011) · Europe PMC (PubMed Central) · Cited by 1
Narrative review of the psychometric properties of language tests used in anomia treatment for primary progressive aphasia (PPA)
Cadório, I., Lousada, M., Martins, P., & de Figueiredo, D. M. P. (2018) · Aphasiology · doi:10.1080/02687038.2018.1508638 · Cited by 1
“Lastly, inter-judge agreement met satisfactory criteria, as variation was inferior to 20% (Schmitt et al., 2007).”
Background
Actigraphy for children with eczema
Wootton, C. I., & Thomas, K. S. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12263 · Cited by 1
Minutes of the HOME III Meeting
Admani, S., Aoki, V., Apfelbacher, C., Ardeleanu, M., Barbarot, S., Berger, T., Bergman, J. N., Borok, N., Burton, T., Chalmers, J. R., et al. (2013) · Cited by 1
Atopic Eczema
Thomas, K. S., Charman, C. R., Nankervis, H., Ravenscroft, J., & Williams, H. C. (2014) · doi:10.1002/9781118357606.ch24 · Cited by 1
Applying the Evidence Back to the Patient
Williams, H. C. (2014) · doi:10.1002/9781118357606.ch18 · Cited by 1
Severity Scoring and Quality of Life Assessment in Atopic Dermatitis
Apfelbacher, C., Prinsen, C. A. C., Heinl, D., & Williams, H. C. (2019) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781119142812.ch16 · Cited by 1
Smartphone apps for caregivers of children with atopic dermatitis : user profile, app scope and co-design
Xu, X. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/137738 · Cited by 1
Outcome Measures
Dupuy, A., Sbidian, É., & Bastuji‐Garin, S. (2014) · doi:10.1002/9781118357606.ch16 · Cited by 1
Area Specific Monitoring of Stratum Corneum Hydration and Transepidermal Water Loss among Atopic Dermatitis PatientsPreprint
Kwon, B. Y., Kim, D., Shim, K., Nguyen, C. N., Lee, H. C., Kang, D., Kim, H., & Seo, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3239607/v1 · Cited by 1
Coated textiles for skin infections
Senti, G., Freiburghaus, A. U., & Kündig, T. M. (2011) · Elsevier eBooks · doi:10.1533/9780857093707.3.186
Aspects of eczema in childhood
Ballardini, N. (2013) · Figshare
Therapeutic challenges in atopic dermatitis
Haeck, I. M. (2010) · Utrecht University Repository (Utrecht University)
Pitfalls and opportunities in the treatment of atopic dermatitis
van Velsen, S. G. A. (2011) · Utrecht University Repository (Utrecht University)
Diagnostic Work-up and Treatment of Severe and/or Refractory Atopic Dermatitis
Devillers, A. C. A. (2009) · RePub (Erasmus University Rotterdam)
Atopic Disease Prevention — A Research Schema for Evaluating Skin Barrier Protection and Phthalate Exposure Reduction
Kirste, L. (2013) · Summit (Simon Fraser University)
The relationship between parents’ self-efficacy beliefs, outcome expectations, child behaviour, and management of atopic dermatitis
Mitchell, A. E. (2011) · Faculty of Health
Psychosocial impact of dermatology diseases
Ahmad, K. A. (2013) · Arrow@dit (Dublin Institute of Technology) · doi:10.34961/7251
Quoi de neuf en dermatologie pédiatrique ?
Stalder, J. ‐. (2007) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(07)80559-x
Trials are meaningful for clinical decision making only when their endpoints are valid and comparable
Schmitt, J. M. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13806
New topical drug development in atopic dermatitis: a place for hope
Paul, C. F. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10913.x
Atopisk dermatitoch behandling
Svensson, Å., & Svedman, C. (2010)
From THE INSTITUTE OF ENVIRONMENTAL MEDICINE
Giuseppe, D. D. (2014)
An exploration of the positive and negative relationships associated with the development of asthma and atopic disorders in primary school children in Cork
Duggan, E. (2013) · Arrow@dit (Dublin Institute of Technology)
Algoritmo diagnóstico en el eccema grave
Córdoba, S., & Borbujo, J. M. (2016) · Piel · doi:10.1016/j.piel.2015.09.020
Questionnaires for pediatric allergic diseases
Yoshida, K., & Akasawa, A. (2014) · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology · doi:10.3388/jspaci.28.237
Allergy Tests in Atopic Dermatitis
der Spek, F. B. D. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-32159-2_4
Complex care for complex eczema in children
Fieten, K. B. (2017) · Utrecht University Repository (Utrecht University)
The Patient-Oriented Eczema Measure (POEM) for Measuring Atopic Eczema Severity
Kido‐Nakahara, M., Yasukochi, Y., Nakahara, T., & Furue, M. (2019) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.81.5
The Measurement, Treatment and Immunopathology of Leprosy Type 1 Reactions
Walker, S. L. (2010) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.04653727
Impacto familiar de la severidad de la dermatitis atópica en menores de 12 años
Consuelo Mosquera, H., & Alvarez, S. A. P. (2017) · Revista de la Facultad de Ciencias Médicas (Quito) · doi:10.29166/ciencias_medicas.v42i2.1500
Algal bloom modeling using genetic programming
Sivapragasam, C., Muttil, N., Muthukumar, S., & Arun, V. (2010) · Victoria University Research Repository (Victoria University)
Efficacy and Safety of Specific Immunotherapy with Aeroallergens in the Management of Atopic Dermatitis: A Systematic Review and Meta-analysisPreprint
Prakoeswa, C. R. S., Anggraeni, S., Damayanti, D., Umborowati, M. A., Riswanto, C. D., Rhatomy, S., Notobroto, H. B., Endaryanto, A., & Effendy, I. (2021) · Research Square · doi:10.21203/rs.3.rs-192958/v1
“SCORAD and Eczema Area and Severity Index (EASI) are some of the recommended results of the assessment signs for AD patients (Schmitt et al., 2007).”
Biophysical characterization of natural antimicrobials towards development of antibacterial skin therapies
Valle‐González, E. R. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/145963
Endophenotype and Biomarker
Lee, K. H., & Park, C. O. (2021) · Springer eBooks · doi:10.1007/978-981-15-8159-5_13
経口的に栄養摂取できない期間には義歯を外す? (看護のエビデンス"いま""むかし"--かつて信じられていたことの何が変わったの?!) -- (摂食・嚥下障害のケア)
深田, 順. (2010) · イー・ビー・ナーシング
Estudo comparativo de concordância e aplicabilidade das escalas de gravidade para dermatite atópica em crianças e adolescentes
Santos, G. S., Barbosa, K. H., & de Paula, C. D. R. (2022) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2020.8284
Can We Decide Which Outcomes Should Be Measured in Every Clinical Trial? A Scoping Review of the Existing Conceptual Frameworks and Processes to Develop Core Outcome Sets
Idzerda, L., Rader, T., Tugwell, P., & Boers, M. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131308.c1
Dermatitis atópica
Pérez, J. S., & García, C. G. (2010) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(10)70015-9
Was juckt es mich, wenn mir die Luft wegbleibt – der atopische Formenkreis
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23796-6.00023-1
Tralokinumab (Adtralza)
CADTH (2022) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2022.364
Clinical Scoring of Atopic Dermatitis
Honari, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-26594-0_94-1
Teledermatology: Research Utilization
Shahriari, N., & Merola, J. F. (2023) · Updates in clinical dermatology · doi:10.1007/978-3-031-27276-9_19
Principles of Measurement and Assessment in Dermatology
Finlay, A. Y., & Ali, F. M. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook016
Pharmacological possibilities of prolongation of atopic dermatitis remissions
Kochergin, N. G. (2024) · Vestnik dermatologii i venerologii · doi:10.25208/vdv16303
A Socioecological Approach to Work Performance
Karni‐Efrati, Z., Egozi, L., & Pardo, A. (2024) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000003265
Dermatoscopic Features of Atopic Dermatitis: A Pilot Study
Yoo, L., Rick, J. W., Shi, V. Y., & Lio, P. (2025) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000415
2.アレルギー性皮膚疾患 : アトピー性皮膚炎,蕁麻疹の重症度と診断の客観的評価法(XI.アレルギー疾患の新しい診断法,専門医のためのアレルギー学講座)
三原, 祥. (2012) · アレルギー · doi:10.15036/arerugi.61.10
Additional file 1 of A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls
Barnes, C. J., Asplund, M., Clausen, M.-L., Rasmussen, L., Olesen, C. M., Yüksel, Y. T., Andersen, P. S., Litman, T., Holmstrøm, K., Bay, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26620867
Additional file 2 of A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls
Barnes, C. J., Asplund, M., Clausen, M.-L., Rasmussen, L., Olesen, C. M., Yüksel, Y. T., Andersen, P. S., Litman, T., Holmstrøm, K., Bay, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26620870
How many instruments do we need? Strengths, weaknesses and potentials for further developments of digital health literacy measurement instruments – a narrative overview of reviews and content analysis (Preprint)Preprint
Kaboth, P., Harst, L., Schmitt, J., & Scheibe, M. (2026) · doi:10.2196/preprints.91603
Investigating the course of atopic eczema up to 1 year following completion of narrowband ultraviolet B phototherapy
Bajaj, S., Desai, P., Singh, A., Jain, D., & Wahie, S. (2026) · Clinical and Experimental Dermatology · doi:10.1093/ced/llag066
How Many Instruments Do We Need? Strengths, Weaknesses, and Potentials for Further Developments of Digital Health Literacy Measurement Instruments: Narrative Overview of Reviews and Content Analysis
Kaboth, P., Harst, L., Schmitt, J. M., & Scheibe, M. (2026) · Interactive Journal of Medical Research · doi:10.2196/91603 · Cited by 1
“This challenge is not limited to DHL but is also present in clinical settings, for example, in the assessment of disease severity using instruments for atopic dermatitis [13].”
Acceptability and feasibility of patient-reported outcome measures for atopic eczema: an evaluation of PROMs from the HOME core outcome set
Dijkstra, J., Knöps, E., Maaskant, J. M., Spuls, P. I., & Gerbens, L. A. A. (2026) · Archives of Dermatological Research · doi:10.1007/s00403-026-04795-1

Authors: Schmitt, J., Langan, S., & Williams, H. C.
Affiliations: University Hospital Carl Gustav Carus (DE)
Queen's Medical Centre (GB)
Corresponding author: Schmitt, Jochen
ORCID: Schmitt, Jochen
Williams, Hywel C.
Venue: Journal of Allergy and Clinical Immunology
Publisher: Elsevier BV
Published: 2007-12
Volume: 120
Issue: 6
Pages: 1389-1398
ISSN: 0091-6749 (ISSN-L)
DOI: 10.1016/j.jaci.2007.08.011
OpenAlex: W1977571789
Cited by: 388
References: 63
Citations by year: 2026: 4 · 2025: 8 · 2024: 19 · 2023: 14 · 2022: 19 · 2021: 22 · 2020: 29 · 2019: 21 · 2018: 22 · 2017: 27 · 2016: 25 · 2015: 20 · 2014: 28 · 2013: 31 · 2012: 22
FWCI: 2.71
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Allergy and Clinical Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords: atopic dermatitis, outcome measures, disease severity assessment, SCORAD, Eczema Area and Severity Index, Patient-Oriented Eczema Measure, construct validity, reliability statistics, sensitivity to change, inter-rater reliability, test-retest reliability, content validity, patient monitoring
MeSH terms: Dermatitis, Atopic, Humans, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

What are the best outcome measurements for atopic eczema? A systematic review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks